Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Acamprosate has no impact on the permeability of paracellular markers across Caco-2 cells
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-062-Monday
- By: ANTONESCU, Irina (University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Odense, Denmark)
- Co-author(s): Irina Antonescu: Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark
Sibylle Neuhoff: Simcyp Ltd., a Certara company, Sheffield, United Kingdom
Bente Steffansen: Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark - Abstract:
Backgrounds
The oral bioavailability of poorly permeable and non-metabolised acamprosate (BCS III) is 11%. It is controversial whether the intestinal effective permeability of the fully an-ionized acamprosate (pKa 1.83; MW 181.2 g/mol) is predominantly paracellular (Ppara) or transcellular. An initial physiologically-based pharmacokinetic model.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023